| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on June 10, 2005
Accepted on October 14, 2005
From the BHF Glasgow Cardiovascular Research Centre, Division of Cardiovascular and Medical Sciences (S.A-B., C.A.H., J.D.M., C.D., A.F.D.), and Robertson Centre for Biostatistics (I.F.), University of Glasgow; the Department of Vascular Surgery (P.N.R.), Gartnavel General Hospital; and Department of Cardiothoracic Surgery (G.A.B.), Western Infirmary, Glasgow, United Kingdom.
* To whom correspondence should be addressed. E-mail: ad7e{at}clinmed.gla.ac.uk.
Objective--There is evidence for a relationship between endothelial dysfunction and cardiovascular disease, but a causative role for oxidative stress remains to be determined.
Methods and Results--We studied 188 patients with severe coronary artery disease (CAD), of whom 51 were age and sex matched with 51 healthy controls undergoing varicose vein surgery. Relaxation of saphenous vein to calcium ionophore, apocynin, and allopurinol was studied together with the markers of oxidative stress, total antioxidant capacity and reduced/oxidized glutathione ratio. Vascular superoxide levels were measured using lucigenin chemiluminescence and hydroethidine. Relaxation to calcium ionophore was decreased in CAD compared with control patients (maximum relaxation 26±2% versus 60±1%; P<0.001). Total superoxide production was increased (0.89±0.09 versus 0.56±0.06 nmol/mg/min; P=0.008), whereas superoxide inhibition with apocynin or allopurinol had a greater effect on vasorelaxation in CAD patients. Low-density lipoprotein (LDL) cholesterol predicted relaxation to calcium ionophore (P<0.001) and oxidative stress markers (P<0.001) in CAD patients.
Conclusions--Endothelial dysfunction is associated with raised levels of superoxide and biomarkers of oxidative stress in saphenous veins from CAD patients. LDL cholesterol is a major determinant of endothelial dysfunction and oxidative stress in these patients. These results support intensive LDL cholesterol-lowering therapy as suggested by recent clinical trials.
This article has been cited by other articles:
![]() |
M. A. Sharif, U. Bayraktutan, N. Arya, S. A. Badger, M. E. O'Donnell, I. S. Young, and C. V. Soong Effects of Antioxidants on Endothelial Function in Human Saphenous Vein in an Ex vivo Model Angiology, August 1, 2009; 60(4): 448 - 454. [Abstract] [PDF] |
||||
![]() |
L A Makivaara, T M Ahti, T Luukkaala, M Hakama, and J O Laurikka Arterial disease but not hypertension predisposes to varicose veins Phlebology, June 1, 2008; 23(3): 142 - 146. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |